Quest Diagnostics (DGX)
(Delayed Data from NYSE)
$155.48 USD
+0.10 (0.06%)
Updated Sep 18, 2024 04:00 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Price, Consensus and EPS Surprise
DGX 155.48 +0.10(0.06%)
Will DGX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for DGX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for DGX
CAH Stock May Gain Following the Distribution Agreement With Telix
Here's Why You Should Retain Accuray Stock in Your Portfolio Now
DGX: What are Zacks experts saying now?
Zacks Private Portfolio Services
NSPR Stock Declines Despite PMA Application Submission for CGuard
Tactile Medical's Shares Rise After PDAC Approval for Nimbl
DGX Stock Likely to Gain From Allina Health's Select Lab Assets Buyout
Other News for DGX
Sentara Health Plans and Quest Diagnostics Form Strategic Collaboration to Extend Lab Access in Parts of the Southeast
Quest Diagnostics and Sentara Health Plans announce collaboration
Quest Diagnostics Completes Acquisition of Select Lab Assets from Allina Health
Quest Diagnostics completes acquisition of certain assets from Allina Health
Morocco reports first mpox case amid ongoing global outbreak